Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC
MUNSTER, Pamela, MARCHION, Douglas, BICAKU, Elona, LACEVIC, Mira, KIM, Jongphil, CENTENO, Barbara, DAUD, Adil, NEUGER, Anthony, MINTON, Susan, SULLIVAN, Daniel
Published in Clinical cancer research (01.04.2009)
Published in Clinical cancer research (01.04.2009)
Get full text
Journal Article
Phase I Trial of Histone Deacetylase Inhibition by Valproic Acid Followed by the Topoisomerase II Inhibitor Epirubicin in Advanced Solid Tumors: A Clinical and Translational Study
MÜNSTER, Pamela, MARCHION, Douglas, CHIAPPORI, Alberto, LUSH, Richard, SULLIVAN, Daniel, DAUD, Adil, BICAKU, Elona, SCHMITT, Morgen, JI HYUN LEE, DECONTI, Ronald, SIMON, George, FISHMAN, Mayer, MINTON, Susan, GARRETT, Chris
Published in Journal of clinical oncology (20.05.2007)
Published in Journal of clinical oncology (20.05.2007)
Get full text
Journal Article
Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial
DAUD, Adil I, DAWSON, Jana, MUNSTER, Pamela N, DECONTI, Ronald C, BICAKU, Elona, MARCHION, Douglas, BASTIEN, Sem, HAUSHEER, Frederick A, LUSH, Richard, NEUGER, Anthony, SULLIVAN, Daniel M
Published in Clinical cancer research (01.04.2009)
Published in Clinical cancer research (01.04.2009)
Get full text
Journal Article
HDAC2 regulates chromatin plasticity and enhances DNA vulnerability
Marchion, Douglas C, Bicaku, Elona, Turner, Joel G, Schmitt, Morgen L, Morelli, Dawn R, Munster, Pamela N
Published in Molecular cancer therapeutics (01.04.2009)
Published in Molecular cancer therapeutics (01.04.2009)
Get full text
Journal Article
Synergistic Interaction between Histone Deacetylase and Topoisomerase II Inhibitors Is Mediated through Topoisomerase IIβ
MARCHION, Douglas C, BICAKU, Elona, TURNER, Joel G, DAUD, Adil I, SULLIVAN, Daniel M, MUNSTER, Pamela N
Published in Clinical cancer research (01.12.2005)
Published in Clinical cancer research (01.12.2005)
Get full text
Journal Article
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
Bansal, Nisha, Marchion, Douglas C, Bicaku, Elona, Xiong, Yin, Chen, Ning, Stickles, Xiaomang B, Sawah, Entidhar Al, Wenham, Robert M, Apte, Sachin M, Gonzalez-Bosquet, Jesus, Judson, Patricia L, Hakam, Ardeshir, Lancaster, Johnathan M
Published in Journal of gynecologic oncology (01.01.2012)
Published in Journal of gynecologic oncology (01.01.2012)
Get full text
Journal Article
BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
MARCHION, Douglas C, COTTRILL, Hope M, HAKAM, Ardeshir, LIHUA LI, DAN SU, MORENO, Carolina, JUDSON, Patricia L, BERCHUCK, Andrew, WENHAM, Robert M, ATE, Sachin M, GONZALEZ-BOSQUET, Jesus, BLOOM, Gregory C, YIN XIONG, ESCHRICH, Steven A, SEBTI, Said, CHEN, Dung-Tsa, LANCASTER, Johnathan M, NING CHEN, BICAKU, Elona, FULP, William J, BANSAL, Nisha, HYE SOOK CHON, STICKLES, Xiaomang B, KAMATH, Siddharth G
Published in Clinical cancer research (01.10.2011)
Published in Clinical cancer research (01.10.2011)
Get full text
Journal Article
BAD-mediated apoptotic pathway is associated with human cancer development
STICKLES, XIAOMANG B, MARCHION, DOUGLAS C, BICAKU, ELONA, SAWAH, ENTIDHAR AL, ABBASI, FOROUGH, XIONG, YIN, ZGHEIB, NADIM BOU, BOAC, BERNADETTE M, ORR, BRIAN C, JUDSON, PATRICIA L, BERRY, AMY, HAKAM, ARDESHIR, WENHAM, ROBERT M, APTE, SACHIN M, BERGLUND, ANDERS E, LANCASTER, JOHNATHAN M
Published in International journal of molecular medicine (01.04.2015)
Published in International journal of molecular medicine (01.04.2015)
Get full text
Journal Article
A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
MARCHION, DOUGLAS C, BICAKU, ELONA, XIONG, YIN, ZGHEIB, NADIM BOU, SAWAH, ENTIDHAR AL, STICKLES, XIAOMANG BA, JUDSON, PATRICIA L, LOPEZ, ALEX S, CUBITT, CHRISTOPHER L, GONZALEZ-BOSQUET, JESUS, WENHAM, ROBERT M, APTE, SACHIN M, BERGLUND, ANDERS, LANCASTER, JOHNATHAN M
Published in Oncology reports (01.05.2013)
Published in Oncology reports (01.05.2013)
Get full text
Journal Article
Abstract C1: HDAC inhibitors trigger the autophagic switch from prosurvival to prodeath in tamoxifen-treated breast cancer cells
Thomas, Scott, Thurn, Kenneth, Miller, Ashleigh, Marchion, Douglas, Bicaku, Elona, Munster, Pamela
Published in Molecular cancer therapeutics (10.12.2009)
Published in Molecular cancer therapeutics (10.12.2009)
Get full text
Journal Article
Abstract 1645: The phosphorylation status of BAD pathway influence to chemo-sensitivity
Chon, Hye Sook, Marchion, Douglas C., Xiong, Yin, Chen, Ning, Bicaku, Elona, Apte, Sachin, Wenham, Robert, Lancaster, Johnathan M.
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer
BOU ZGHEIB, Nadim, YIN XIONG, WENHAM, Robert M, APTE, Sachin M, CUBITT, Christopher L, TSA CHEN, Dung, LANCASTER, Johnathan M, MARCHION, Douglas C, BICAKU, Elona, SOOK CHON, Hye, BA STICKLES, Xiaomang, AL SAWAH, Entidhar, JUDSON, Patricia L, HAKAM, Ardeshir, GONZALEZ-BOSQUET, Jesus
Published in International journal of oncology (01.07.2012)
Published in International journal of oncology (01.07.2012)
Get full text
Journal Article
BAD phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
Marchion, Douglas C., Cottrill, Hope M., Xiong, Yin, Chen, Ning, Bicaku, Elona, Fulp, William J., Bansal, Nisha, Chon, Hye Sook, Stickles, Xiaomang B., Kamath, Siddharth G., Hakam, Ardeshir, Li, Lihua, Su, Dan, Moreno, Carolina, Judson, Patricia L., Berchuck, Andrew, Wenham, Robert M., Apte, Sachin M., Gonzalez-Bosquet, Jesus, Bloom, Gregory C., Eschrich, Steven A., Sebti, Said, Chen, Dung-Tsa, Lancaster, Johnathan M.
Published in Clinical cancer research (17.08.2011)
Published in Clinical cancer research (17.08.2011)
Get full text
Journal Article
Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta
Marchion, Douglas C, Bicaku, Elona, Turner, Joel G, Daud, Adil I, Sullivan, Daniel M, Munster, Pamela N
Published in Clinical cancer research (01.12.2005)
Get full text
Published in Clinical cancer research (01.12.2005)
Journal Article